JAMES BOCHNOWSKI
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
JULIET BAKKER, JULIET T. BAKKER, EVELYN BLAKE, RONALD BLUM, RONALD D. BLUM, JAMES J. BOCHNOWSKI, PETER BONI, BRETT H. CRAIG, LINDA GORENS-LEVEY, STEVE HOLT, WILLIAM KOKONASKI, GARY KURTZMAN, JERRY OSTROV, MICHAEL B. PACKARD, MIKE PACKARD, RYAN SCHWARZ, RYAN M. SCHWARZ, BRIAN J. STARK, ANN-KELLEY WINN, STEPHEN T ZARRILLI, STEPHEN T. ZARRILLI
DIRECTOR
DIRECTOR
ARI AZHIR, JAMES J. BOCHNOWSKI, JOSEPH BOCHNOWSKI, PRAVIN CHATURVEDI, LISA CONTE, GREG DIVAS, GREG DIVIS, GREG J. DIVIS, ANULA JAYASURIYA, JEFFERY JOHNSON, JEFFREY JOHNSON, JEFFREY B. JOHNSON, JEFFREY C JOHNSON, JEFFREY C. JOHNSON, JOHN KALLASSY, JOHN A. KALLASSY, FOLKERT KAMPHUIS, STEVEN KING, STEVEN R. KING, CAROL LIZAK, MURRAY MACNAUGHTAN, MURRAY DAVID MACNAUGHTAN, SERGE MARTINOD, JOHN MICEK III, JOHN MICEK, III, JIAHAO QUI, JIAHAO JIAHAO QUI, JOE QUI, JONATHAN SIEGEL, JONATHAN B SIEGEL, JONATHAN B. SIEGEL, CHARLES THOMPSON, CHARLES THOMSPN, JONATHAN WOLIN, JONATHAN WOLING, KAREN WRIGHT, KAREN S. WRIGHT, ZHI YANG
DIRECTOR
DIRECTOR
DIRECTOR
ARI AZHIR, JAMES J. BOCHNOWSKI, JOSEPH BOCHNOWSKI, PRAVIN CHATURVEDI, LISA CONTE, GREG DIVAS, GREG DIVIS, GREG J. DIVIS, ANULA JAYASURIYA, JEFFERY JOHNSON, JEFFREY JOHNSON, JEFFREY B. JOHNSON, JEFFREY C JOHNSON, JEFFREY C. JOHNSON, JOHN KALLASSY, JOHN A. KALLASSY, FOLKERT KAMPHUIS, STEVEN KING, STEVEN R. KING, CAROL LIZAK, MURRAY MACNAUGHTAN, MURRAY DAVID MACNAUGHTAN, SERGE MARTINOD, JOHN MICEK III, JOHN MICEK, III, JIAHAO QUI, JIAHAO JIAHAO QUI, JOE QUI, JONATHAN SIEGEL, JONATHAN B SIEGEL, JONATHAN B. SIEGEL, CHARLES THOMPSON, CHARLES THOMSPN, JONATHAN WOLIN, JONATHAN WOLING, KAREN WRIGHT, KAREN S. WRIGHT, ZHI YANG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-06-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-06-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2025-11-12
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-09-28
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-09-10
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-09-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-05-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-05-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-08-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-06-28
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-09-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-04-05
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-03-07
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-09-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-03-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-12-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-01-19
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-03-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-03-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-24
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2018-03-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2018-03-26
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-06-29
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-12-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-12-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-07-31
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2015-03-20
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-12-23
D
BUSINESS SERVICES
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-12-03

